Abstract: In example methods and systems described, insulin therapy for a patient can be determined. At least one of a short-acting subcutaneous insulin dosage recommendation, a correction subcutaneous insulin dosage recommendation, an intravenous insulin dosage recommendation, a recommended amount of carbohydrates to be administered to the patient, or combinations thereof, can be determined. In addition, information indicating a confirmation of a nutrition intake for the patient, and a long-acting insulin-on-board for the patient can be received, and based on this information, a required long-acting subcutaneous or intravenous insulin dosage for the patient can be determined. The short-acting subcutaneous or intravenous insulin dosage recommendation can be adjusted based, at least in part, on a difference between the long-acting insulin-on-board and the required long-acting subcutaneous or intravenous insulin dosage.

Abstract: In example methods and systems described, insulin therapy for a patient can be determined. At least one of a short-acting subcutaneous insulin dosage recommendation, a correction subcutaneous insulin dosage recommendation, an intravenous insulin dosage recommendation, a recommended amount of carbohydrates to be administered to the patient, or combinations thereof, can be determined. In addition, information indicating a confirmation of a nutrition intake for the patient, and a long-acting insulin-on-board for the patient can be received, and based on this information, a required long-acting subcutaneous or intravenous insulin dosage for the patient can be determined. The short-acting subcutaneous or intravenous insulin dosage recommendation can be adjusted based, at least in part, on a difference between the long-acting insulin-on-board and the required long-acting subcutaneous or intravenous insulin dosage.

Abstract: In example methods and systems described, insulin therapy for a patient can be determined. At least one of a short-acting subcutaneous insulin dosage recommendation, a correction subcutaneous insulin dosage recommendation, an intravenous insulin dosage recommendation, a recommended amount of carbohydrates to be administered to the patient, or combinations thereof, can be determined. In addition, information indicating a confirmation of a nutrition intake for the patient, and a long-acting insulin-on-board for the patient can be received, and based on this information, a required long-acting subcutaneous or intravenous insulin dosage for the patient can be determined. The short-acting subcutaneous or intravenous insulin dosage recommendation can be adjusted based, at least in part, on a difference between the long-acting insulin-on-board and the required long-acting subcutaneous or intravenous insulin dosage.

Abstract: In example methods and systems described, insulin therapy for a patient can be determined. At least one of a short-acting subcutaneous insulin dosage recommendation, a correction subcutaneous insulin dosage recommendation, an intravenous insulin dosage recommendation, a recommended amount of carbohydrates to be administered to the patient, or combinations thereof, can be determined. In addition, information indicating a confirmation of a nutrition intake for the patient, and a long-acting insulin-on-board for the patient can be received, and based on this information, a required long-acting subcutaneous or intravenous insulin dosage for the patient can be determined. The short-acting subcutaneous or intravenous insulin dosage recommendation can be adjusted based, at least in part, on a difference between the long-acting insulin-on-board and the required long-acting subcutaneous or intravenous insulin dosage.

Abstract: In example methods and systems described, insulin therapy for a patient can be determined. At least one of a short-acting subcutaneous insulin dosage recommendation, a correction subcutaneous insulin dosage recommendation, an intravenous insulin dosage recommendation, a recommended amount of carbohydrates to be administered to the patient, or combinations thereof, can be determined. In addition, information indicating a confirmation of a nutrition intake for the patient, and a long-acting insulin-on-board for the patient can be received, and based on this information, a required long-acting subcutaneous or intravenous insulin dosage for the patient can be determined. The short-acting subcutaneous or intravenous insulin dosage recommendation can be adjusted based, at least in part, on a difference between the long-acting insulin-on-board and the required long-acting subcutaneous or intravenous insulin dosage.

Abstract: Electrical devices having a plurality of stacked electrode layers are described. At least one of the electrode layers contains continuous fibers that are infused with carbon nanotubes. The continuous fibers can be disposed upon an electrically conductive base plate. The electrical devices can further contain an electrolyte contacting each electrode layer and a layer of separator material disposed between each electrode layer, in which case the electrical devices can form a supercapacitor. Such supercapacitors can have a capacitance of at least about 1 Farad/gram of continuous fibers. The capacitance can be increased by coating at least a portion of the infused carbon nanotubes with a material such as, for example, a conducting polymer, a main group metal compound, and/or a transition metal compound. Methods for producing the electrical devices are also described.

Abstract: A carbon nanostructure that is free of a growth substrate can include a plurality of carbon nanotubes that are branched, crosslinked, and share common walls with one another. The carbon nanostructure can be released from a growth substrate in the form of a flake material. Optionally, the carbon nanotubes of the carbon nanostructure can be coated, such as with a polymer, or a filler material can be present within the porosity of the carbon nanostructure. Methods for forming a carbon nanostructure that is free of a growth substrate can include providing a carbon nanostructure adhered to a growth substrate, and removing the carbon nanostructure from the growth substrate to form a carbon nanostructure that is free of the growth substrate. Various techniques can be used to affect removal of the carbon nanostructure from the growth substrate. Isolation of the carbon nanostructure can further employ various wet and/or dry separation techniques.

Abstract: An energy storage device can include at least one electrode that comprise a plurality carbon nanostructure (CNS)-infused fibers in contact with an active material and an electrolyte.

Abstract: The electrical conductivity of ionically conductive polymers can be increased by polymerizing a mixture of a polymer precursor and an electrolyte in the presence of an electric field. Methods for making ionically conductive polymers can include providing a mixture containing an electrolyte and a polymer precursor, and polymerizing the polymer precursor while applying an electric field to the mixture. Ionically conductive polymers so prepared can be used in electrical devices. Methods for making electrical devices containing the ionically conductive polymers are also described.

Abstract: Electrical devices having a plurality of stacked electrode layers are described. At least one of the electrode layers contains continuous fibers that are infused with carbon nanotubes. The continuous fibers can be disposed upon an electrically conductive base plate. The electrical devices can further contain an electrolyte contacting each electrode layer and a layer of separator material disposed between each electrode layer, in which case the electrical devices can form a supercapacitor. Such supercapacitors can have a capacitance of at least about 1 Farad/gram of continuous fibers. The capacitance can be increased by coating at least a portion of the infused carbon nanotubes with a material such as, for example, a conducting polymer, a main group metal compound, and/or a transition metal compound. Methods for producing the electrical devices are also described.